TP53 and familial pancreatic carcinoma: An interesting observation, based on pancreatic cancer patient–derived xenografts, is that lack of p53 function sensitizes tumors to inhibition of lactate dehydrogenase (40), indicating a link between p53 function and glycolysis in pancreatic cancer.